Eli Lilly Stock Gains as Retatrutide and Foundayo Data Highlight Pipeline Strength
Shares of Eli Lilly and Company (NYSE: LLY ) are trading higher Tuesday morning following positive previews of its late-stage obesity and diabetes pipeline. Eli Lilly stock is trading near recent highs. What’s next for LLY stock? EASD 2026 Pipeline Previews Highlight Retatrutide and Foundayo Momentum The morning upside